Coupled Model of Blood Volume and Activated Clotting Factor Concentration during Childbirth

Michelle A Pressly1, Matthew D Neal2,3, Jonathan H Waters4,5

  • 1Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA 15261 USA.

Ifac-Papersonline
|February 18, 2021
PubMed

Obstetric patients show an increased risk of developing venous thromboembolism (VTE). Modeling the changes that occur during and after delivery may help determine which patients will develop VTE and when they might be likely to develop this dangerous complication after delivery. Combining a model of blood volume changes with a model of activated clotting factor concentrations, which are both affected during delivery, can identify scenarios that may lead to an increased risk of developing clots in the venous vascular space. This Ordinary Differential Equation (ODE) model recapitulates known phenomena including an elevated coagulation response during delivery and hemorrhage leading to increased clotting factor concentration in the vascular space. The simulation from normal activation without hemorrhage results in a spike in clotting factors in the vascular space to reestablish hemostasis after delivery. With twice the activation rate, simulations show elevated and extended duration of activated clotting factor presence in the vascular space. With response to a hemorrhage with normal activation, the resulting elevation and duration is further increased. This model, when tailored to individual patients, could lead to the development of a VTE risk assessment tool for clinicians to help mitigate and reduce an individual's risk of developing this deadly complication.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.7K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.7K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.1K